Related Experiment Video
Updated: Jul 27, 2025

09:43
Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
Published on: March 8, 2024
1.8K
Secretion Function Analysis of Ex Vivo Immune Cells in an Integrated Microfluidic Device
Roberto Rodriguez-Moncayo1,2, Jose L Garcia-Cordero3,4
1Laboratory of Microtechnologies Applied to Biomedicine, Centro de Investigación y Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav), Monterrey, NL, Mexico.
Methods in Molecular Biology (Clifton, N.J.)
|June 10, 2023
Summary
Analyzing immune cell secretions ex vivo can predict cancer prognosis. A novel microfluidic device enhances throughput and reduces sample needs for this crucial cancer biomarker analysis.
Area of Science:
- Immunology
- Oncology
- Biomedical Engineering
Background:
- Immune cells critically influence cancer development, exhibiting dual roles in inhibition and promotion through secreted factors.
- Ex vivo analysis of immune cell secretion functions offers a potential prognostic biomarker for cancer.
- Current methods for analyzing immune cell secretions are limited by low throughput and high sample consumption.
Purpose of the Study:
- To develop a microfluidic device for high-throughput, low-sample-volume analysis of ex vivo immune cell secretion functions.
- To establish a more efficient and reliable method for assessing immune cell secretory profiles as cancer biomarkers.
Main Methods:
- Design and fabrication of a highly integrated microfluidic device incorporating cell culture and biosensing capabilities.
- Utilizing microfluidics to control fluid dynamics, enabling automation and consistent analysis of immune cell secretions.
- Demonstrating the device's capacity for analyzing the ex vivo secretion function of immune cells.
Main Results:
- The microfluidic device integrates essential components for cell analysis on a single platform.
- The approach significantly increases analytical throughput while minimizing sample volume requirements.
- Automation features enhance the consistency and reliability of ex vivo immune cell secretion analysis.
Conclusions:
- A novel microfluidic device enables efficient and reliable ex vivo analysis of immune cell secretion functions.
- This technology holds promise for advancing the use of immune cell secretions as prognostic cancer biomarkers.
- The integrated microfluidic approach overcomes limitations of traditional methods, paving the way for improved cancer diagnostics.

